By analyzing regions of YKL-40/OLIG2 expression, we preclassified glioblastoma tumors into proneural and mesenchymal glioblastoma subtypes (35/38; segregation efficacy 92.0%). This evidence concerns the gene CHI3L1 and glioblastoma.